XML 52 R42.htm IDEA: XBRL DOCUMENT v3.24.3
Shareholders Equity (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 11, 2021
shares
Sep. 30, 2024
USD ($)
shares
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
D
shares
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
May 27, 2021
$ / shares
shares
Shareholders' Equity              
Conversion, threshold percentage of market price   95.00%   95.00%      
Gain (loss) recognized for the change in liability | $   $ 2,944 $ (7,637) $ 12,538 $ 44,578    
0.75% senior exchangeable notes due January 2024              
Shareholders' Equity              
Interest rate (as a percent)           0.75%  
5.75% senior notes due February 2025              
Shareholders' Equity              
Interest rate (as a percent)           5.75%  
Common share warrants              
Shareholders' Equity              
Number of warrants received per common share held             0.40
Number of warrants issued 3,200,000            
Number of business day notice period | D       20      
Fair value of outstanding warrants | $   $ 13,400   $ 13,400   $ 25,900  
Warrants outstanding   2,500,000   2,500,000      
Common share warrants | Other, net              
Shareholders' Equity              
Gain (loss) recognized for the change in liability | $   $ 2,900 $ (7,900) $ 12,500 $ 44,300    
Common Shares              
Shareholders' Equity              
Aggregate number of shares issued from the exercise of warrants   1,100,000   1,100,000      
Number of shares which may be purchased by each right             1
Exercise price (in dollars per share) | $ / shares             $ 166.66667